Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.

NCT05272878 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

508

Enrollment

OTHER

Sponsor class

Conditions

Acute Kidney Injury

Interventions

DRUG: IRBESARTAN, tablet, 150 mg
DRUG: Placebo, tablet, 150 mg

Sponsor

Assistance Publique - Hôpitaux de Paris